Baker Bros. Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Baker Bros. Advisors’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$955M	Hold	42,896,690	–	–	5.48%	5
2025 Q4	$1.15B	Hold	42,896,690	–	–	6.71%	5
2025 Q3	$915M	Hold	42,896,690	–	–	6.61%	5
2025 Q2	$925M	Buy	42,896,690 +18,774	+0%	+$349K	8.98%	3
2025 Q1	$712M	Hold	42,877,916	–	–	7.88%	3
2024 Q4	$787M	Hold	42,877,916	–	–	8.4%	3
2024 Q3	$659M	Hold	42,877,916	–	–	6.83%	3
2024 Q2	$697M	Buy	42,877,916 +13,304	+0%	+$215K	8.9%	3
2024 Q1	$793M	Hold	42,864,612	–	–	9.94%	3
2023 Q4	$1.34B	Hold	42,864,612	–	–	15.27%	3
2023 Q3	$893M	Hold	42,864,612	–	–	5.15%	4
2023 Q2	$1.03B	Buy	42,864,612 +926,126	+2%	+$20.6M	5.94%	4
2023 Q1	$789M	Buy	41,938,486 +15,000	+0%	+$286K	4.29%	4
2022 Q4	$667M	Hold	41,923,486	–	–	4.01%	5
2022 Q3	$686M	Hold	41,923,486	–	–	4.49%	4
2022 Q2	$591M	Buy	41,923,486 +12,782	+0%	+$239K	3.35%	5
2022 Q1	$1.02B	Hold	41,910,704	–	–	5.83%	4
2021 Q4	$978M	Hold	41,910,704	–	–	4.76%	5
2021 Q3	$696M	Hold	41,910,704	–	–	3.06%	6
2021 Q2	$1.02B	Hold	41,910,704	–	–	4.49%	5
2021 Q1	$1.08B	Buy	41,910,704 +6,118	+0%	+$269K	4.69%	5
2020 Q4	$2.24B	Hold	41,904,586	–	–	8.44%	4
2020 Q3	$1.73B	Hold	41,904,586	–	–	6.91%	4
2020 Q2	$2.03B	Hold	41,904,586	–	–	8.96%	4
2020 Q1	$1.77B	Buy	41,904,586 +1,050,000	+3%	+$43.3M	10.9%	3
2019 Q4	$1.75B	Hold	40,854,586	–	–	9.29%	4
2019 Q3	$1.47B	Buy	40,854,586 +1,562,500	+4%	+$47.4M	10%	3
2019 Q2	$1.05B	Sell	39,292,086 -421,756	-1%	-$10.8M	7.14%	5
2019 Q1	$1.07B	Hold	39,713,842	–	–	6.83%	5
2018 Q4	$642M	Buy	39,713,842 +11,274,728	+40%	+$219M	5.26%	7
2018 Q3	$590M	Buy	28,439,114 +1,210,776	+4%	+$19M	3.89%	7
2018 Q2	$416M	Hold	27,228,338	–	–	3.12%	7
2018 Q1	$612M	Hold	27,228,338	–	–	5.19%	6
2017 Q4	$820M	Buy	27,228,338 +1,408,570	+5%	+$45M	7.11%	4
2017 Q3	$973M	Hold	25,819,768	–	–	7.89%	4
2017 Q2	$720M	Hold	25,819,768	–	–	6.3%	4
2017 Q1	$888M	Hold	25,819,768	–	–	7.26%	3
2016 Q4	$745M	Hold	25,819,768	–	–	7.3%	4
2016 Q3	$821M	Buy	25,819,768 +1,303,030	+5%	+$44.2M	7.45%	4
2016 Q2	$796M	Buy	24,516,738 +302,900	+1%	+$10.1M	8.34%	4
2016 Q1	$677M	Buy	24,213,838 +3,732,396	+18%	+$81.4M	7.14%	5
2015 Q4	$730M	Hold	20,481,442	–	–	6.05%	5
2015 Q3	$677M	Hold	20,481,442	–	–	6.26%	5
2015 Q2	$858M	Hold	20,481,442	–	–	7.52%	5
2015 Q1	$667M	Hold	20,481,442	–	–	5.55%	6
2014 Q4	$650M	Hold	20,481,442	–	–	6.64%	6
2014 Q3	$507M	Hold	20,481,442	–	–	6.48%	6
2014 Q2	$463M	Hold	20,481,442	–	–	5.67%	6
2014 Q1	$498M	Buy	20,481,442 +526,316	+3%	+$13.3M	6.33%	5
2013 Q4	$499M	Hold	19,955,126	–	–	7.03%	5
2013 Q3	$548M	Hold	19,955,126	–	–	7.79%	6
2013 Q2	$362M	Buy	+19,955,126	New	+$275M	7.16%	6